Terms: = Prostate cancer AND EIF3E, eIF3-p46, 3646, ENSG00000104408, EIF3S6, eIF3e, EIF3-P48, INT6
8 results:
1. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Ahmed HU; El-Shater Bosaily A; Brown LC; Gabe R; Kaplan R; Parmar MK; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham AP; Oldroyd R; Parker C; Emberton M;
Lancet; 2017 Feb; 389(10071):815-822. PubMed ID: 28110982
[TBL] [Abstract] [Full Text] [Related]
2. cancer incidence in Khartoum, Sudan: first results from the cancer Registry, 2009-2010.
Saeed IE; Weng HY; Mohamed KH; Mohammed SI
Cancer Med; 2014 Aug; 3(4):1075-84. PubMed ID: 24821265
[TBL] [Abstract] [Full Text] [Related]
3. Predictors of positive surgical margins and their location in Korean men undergoing radical prostatectomy.
Choo MS; Cho SY; Jeong CW; Lee SB; Ku JH; Hong SK; Byun SS; Kwak C; Kim HH; Lee SE; Jeong H
Int J Urol; 2014 Sep; 21(9):894-8. PubMed ID: 24807736
[TBL] [Abstract] [Full Text] [Related]
4. [Expression of PIM-1 in prostate cancer tissue and its relationship with PSA recurrence].
Zhang CT; Xu Y; Luo F; Zhang ZH; Liu RL; Yang K; Ma BJ
Zhonghua Nan Ke Xue; 2012 Apr; 18(4):323-6. PubMed ID: 22574367
[TBL] [Abstract] [Full Text] [Related]
5. [Drug discovery by formulation design and innovative drug delivery systems (DDS)].
Okada H
Yakugaku Zasshi; 2011; 131(9):1271-87. PubMed ID: 21881300
[TBL] [Abstract] [Full Text] [Related]
6. Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: estimation for the Portuguese National Health System.
Félix J; Andreozzi V; Soares M; Borrego P; Gervásio H; Moreira A; Costa L; Marcelo F; Peralta F; Furtado I; Pina F; Albuquerque C; Santos A; Passos-Coelho JL;
Value Health; 2011 Jun; 14(4):499-505. PubMed ID: 21669375
[TBL] [Abstract] [Full Text] [Related]
7. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.
Ranieri G; Patruno R; Ruggieri E; Montemurro S; Valerio P; Ribatti D
Curr Med Chem; 2006; 13(16):1845-57. PubMed ID: 16842197
[TBL] [Abstract] [Full Text] [Related]
8. Prostatic specific antigen as an indicator of response to radiotherapy in prostate cancer.
Landmann C; Hunig R
Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1073-6. PubMed ID: 2478510
[TBL] [Abstract] [Full Text] [Related]
